SANOFI INDIA
|
SANOFI INDIA Last 5 Year Financial Ratios History
[Standalone]
| Dec2024 | Dec2023 | Dec2022 | Dec2021 | Dec2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 136.39 | 158.52 | 269.83 | 410.61 | 207.65 |
| CEPS(Rs) | 152.35 | 174.39 | 288.04 | 439.61 | 243.39 |
| DPS(Rs) | 117.00 | 167.00 | 570.00 | 490.00 | 365.00 |
| Book NAV/Share(Rs) | 343.96 | 411.83 | 527.65 | 941.52 | 897.83 |
| Tax Rate(%) | 27.28 | 31.01 | 28.20 | 24.90 | 29.47 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 23.76 | 23.50 | 24.09 | 25.78 | 24.57 |
| EBIT Margin(%) | 20.97 | 25.58 | 29.68 | 42.60 | 23.40 |
| Pre Tax Margin(%) | 20.90 | 25.50 | 29.62 | 42.54 | 23.34 |
| PAT Margin (%) | 15.20 | 17.59 | 21.27 | 31.94 | 16.46 |
| Cash Profit Margin (%) | 16.98 | 19.35 | 22.70 | 34.20 | 19.29 |
| Performance Ratios | |||||
| ROA(%) | 6.69 | 7.65 | 11.95 | 17.74 | 9.24 |
| ROE(%) | 36.09 | 33.75 | 36.73 | 44.65 | 21.39 |
| ROCE(%) | 46.15 | 46.28 | 49.47 | 57.98 | 29.77 |
| Asset Turnover(x) | 0.44 | 0.43 | 0.56 | 0.56 | 0.56 |
| Sales/Fixed Asset(x) | 3.71 | 3.86 | 5.42 | 4.23 | 3.48 |
| Working Capital/Sales(x) | 5.06 | 3.48 | 3.36 | 2.13 | 2.53 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.27 | 0.26 | 0.18 | 0.24 | 0.29 |
| Receivable days | 31.98 | 22.96 | 17.01 | 17.96 | 23.40 |
| Inventory Days | 102.89 | 94.36 | 50.06 | 46.94 | 52.68 |
| Payable days | 130.04 | 124.01 | 112.47 | 97.06 | 100.04 |
| Valuation Parameters | |||||
| PER(x) | 44.88 | 50.89 | 21.68 | 19.22 | 40.06 |
| PCE(x) | 40.18 | 46.26 | 20.31 | 17.95 | 34.17 |
| Price/Book(x) | 17.80 | 19.59 | 11.09 | 8.38 | 9.26 |
| Yield(%) | 1.91 | 2.07 | 9.74 | 6.21 | 4.39 |
| EV/Net Sales(x) | 6.85 | 9.09 | 4.49 | 5.62 | 6.18 |
| EV/Core EBITDA(x) | 27.17 | 33.07 | 16.03 | 19.84 | 22.32 |
| EV/EBIT(x) | 31.84 | 34.23 | 14.36 | 13.18 | 26.40 |
| EV/CE(x) | 16.02 | 17.87 | 9.75 | 2.99 | 3.52 |
| M Cap / Sales | 6.99 | 9.30 | 4.86 | 6.14 | 6.59 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 0.86 | -27.94 | -6.31 | 1.88 | -5.49 |
| Core EBITDA Growth(%) | -7.58 | -29.26 | -7.29 | 4.23 | 5.73 |
| EBIT Growth(%) | -18.35 | -38.78 | -31.24 | 85.48 | 13.13 |
| PAT Growth(%) | -13.96 | -41.25 | -34.29 | 97.74 | 15.31 |
| EPS Growth(%) | -13.96 | -41.25 | -34.29 | 97.74 | 15.31 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 1.16 | 1.23 | 1.32 | 1.60 | 1.68 |
| Quick Ratio(x) | 0.96 | 0.97 | 1.17 | 1.43 | 1.46 |
| Interest Cover(x) | 288.60 | 311.88 | 509.41 | 699.67 | 377.22 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of SANOFI INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SANOFI INDIA | ₹11,060.9 Cr | 2% | 2.1% | -25.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,751.0 Cr | 0.2% | 7.1% | -7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,634.0 Cr | 1% | 16.8% | 12.7% | Stock Analytics | |
| CIPLA | ₹124,437.0 Cr | -2.7% | 3.5% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,871.0 Cr | 0.6% | 0.4% | 4.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,333.0 Cr | -6.4% | -2.7% | -3.9% | Stock Analytics | |
SANOFI INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SANOFI INDIA | 2% |
2.1% |
-25.7% |
| SENSEX | -0.2% |
5% |
5.4% |
You may also like the below Video Courses
